Regen BioPharma Inc (RGBP)
0.085
0.00 (0.00%)
USD |
OTCM |
Nov 22, 16:00
Regen BioPharma EPS Diluted (Quarterly): -0.015 for June 30, 2024
EPS Diluted (Quarterly) Chart
Historical EPS Diluted (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2024 | -0.015 |
| March 31, 2024 | -0.015 |
| December 31, 2023 | -0.05 |
| September 30, 2023 | -0.05 |
| June 30, 2023 | -0.015 |
| March 31, 2023 | -0.015 |
| December 31, 2022 | 0.225 |
| September 30, 2022 | -0.0049 |
| June 30, 2022 | 9.555 |
| March 31, 2022 | -11.02 |
| December 31, 2021 | 0.75 |
| September 30, 2021 | -0.1875 |
| June 30, 2021 | -1.575 |
| March 31, 2021 | 0.15 |
| December 31, 2020 | 0.5873 |
| September 30, 2020 | 0.525 |
| June 30, 2020 | 1.20 |
| March 31, 2020 | -1.95 |
| December 31, 2019 | 2.25 |
| September 30, 2019 | 2.347 |
| June 30, 2019 | -38.55 |
| March 31, 2019 | -0.825 |
| December 31, 2018 | 0.525 |
| Date | Value |
|---|---|
| September 30, 2018 | -4.35 |
| June 30, 2018 | -0.525 |
| March 31, 2018 | -5.85 |
| December 31, 2017 | -14.62 |
| September 30, 2017 | -7.275 |
| June 30, 2017 | -14.25 |
| March 31, 2017 | -6.975 |
| December 31, 2016 | -2.925 |
| September 30, 2016 | -5.40 |
| June 30, 2016 | -5.85 |
| March 31, 2016 | -4.35 |
| December 31, 2015 | -4.189 |
| September 30, 2015 | -2.925 |
| June 30, 2015 | -5.625 |
| March 31, 2015 | -6.60 |
| December 31, 2014 | -3.15 |
| September 30, 2014 | -2.812 |
| June 30, 2014 | -2.399 |
| March 31, 2014 | -2.698 |
| December 31, 2013 | -3.00 |
| September 30, 2013 | -1.708 |
| June 30, 2013 | -1.084 |
| March 31, 2013 | -1.022 |
Earnings per Share Definition
Earnings per share measures the total net income / average shares outstanding during income period. There are a few variations to earnings per share that are listed including "EPS Basic", "EPS Diluted", "Normalized Basic EPS", and "Normalized Diluted EPS". Each of these metrics are dependent on which earnings and shares outstanding metrics are used. Basic and Diluted EPS differ in that diluted shares are the amount of shares outstanding after all convertible securities, options, and warrants are exercised. Normalized EPS allows does not include one-time expenses.
EPS Diluted (Quarterly) Range, Past 5 Years
-11.02
Minimum
Mar 2022
9.555
Maximum
Jun 2022
0.0182
Average
-0.015
Median
Mar 2023
EPS Diluted (Quarterly) Benchmarks
| Aethlon Medical Inc | -0.20 |
| AIM ImmunoTech Inc | -0.06 |
| Perspective Therapeutics Inc | -0.21 |
| Protalix BioTherapeutics Inc | 0.03 |
| Armata Pharmaceuticals Inc | -0.15 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -0.1171M |
| Revenue (Quarterly) | 0.0591M |
| Total Expenses (Quarterly) | 0.167M |
| Enterprise Value | 1.424M |
| Profit Margin (Quarterly) | -198.3% |
| Earnings Yield | -152.9% |
| Normalized Earnings Yield | -119.40 |